
FDA Warns of Serious Side Effects Associated with Fluoroquinolone Drugs
FDA is advising there may be serious and potentially permanent side effects associated with taking fluoroquinolone antibacterial drugs consistently.
FDA is advising that the serious side effects associated with fluoroquinolone antibacterial drugs may outweigh the benefits for patients with sinusitis, bronchitis, and uncomplicated urinary tract infections, the agency said in a May 12, 2016
FDA will now require fluoroquinolone’s labels be updated with the new safety information, the agency said in a safety announcement. FDA previously released safety warnings about the safety of fluoroquinolones in 2008 and 2013. In July 2008,
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.